EX-10.5 6 dex105.htm AMENDED & RESTATED SEVERANCE AGREEMENT OF IZUMI HARA. EXECUTION COPY AMENDED AND RESTATED SEVERANCE AGREEMENT – SENIOR VICE PRESIDENTSeverance Agreement • May 5th, 2020 • New Jersey
Contract Type FiledMay 5th, 2020 JurisdictionTHIS AMENDED AND RESTATED SEVERANCE AGREEMENT (the “Agreement”) is made as of November 7, 2008, between WARNER CHILCOTT (US), LLC (formerly named Warner Chilcott (US), Inc.) (the “Company”) and Izumi Hara (“Executive”).
SECOND AMENDED AND RESTATED SEVERANCE AGREEMENT – SENIOR VICE PRESIDENTSeverance Agreement • May 10th, 2013 • Warner Chilcott PLC • Pharmaceutical preparations • New Jersey
Contract Type FiledMay 10th, 2013 Company Industry JurisdictionTHIS SECOND AMENDED AND RESTATED SEVERANCE AGREEMENT (the “Agreement”) is made as of August 26, 2011, between WARNER CHILCOTT (US), LLC (the “Company”), and Alvin D. Howard (“Executive”).
AMENDED AND RESTATED SEVERANCE AGREEMENT – SENIOR VICE PRESIDENTSeverance Agreement • November 10th, 2008 • Warner Chilcott LTD • Pharmaceutical preparations • New Jersey
Contract Type FiledNovember 10th, 2008 Company Industry JurisdictionTHIS AMENDED AND RESTATED SEVERANCE AGREEMENT (the “Agreement”) is made as of November 7, 2008, between WARNER CHILCOTT (US), LLC (formerly named Warner Chilcott (US), Inc.) (the “Company”) and Izumi Hara (“Executive”).
SEVERANCE AGREEMENT – SENIOR VICE PRESIDENTSeverance Agreement • July 18th, 2005 • Warner Chilcott CORP • New Jersey
Contract Type FiledJuly 18th, 2005 Company JurisdictionTHIS SEVERANCE AGREEMENT (the “Agreement”) is made as of March 28, 2005, between WARNER CHILCOTT (US), INC. (formerly named Warner Chilcott, Inc.) (the “Company”) and Herman Ellman (“Executive”).
SEVERANCE AGREEMENT – SENIOR VICE PRESIDENTSeverance Agreement • July 18th, 2005 • Warner Chilcott CORP • New Jersey
Contract Type FiledJuly 18th, 2005 Company JurisdictionTHIS SEVERANCE AGREEMENT (the “Agreement”) is made as of March 28, 2005, between WARNER CHILCOTT (US), INC. (formerly named Warner Chilcott, Inc.) (the “Company”) and Leland H. Cross (“Executive”).